retatrutide fatty liver disease significantly improved health in patients with non-alcoholic liver Experimental weight loss drug could

Sarcopenia, the clinical term for loss of muscle mass and strength, is typically associated with aging patients

In rodent models, GLP-1 receptor activation significantly reduced alcohol intake, likely by modifying the reward pathways involved in alcohol consumption

Frequently Asked Questions When will retatrutide be available

Warning Letters to Telehealth providers marketing GLP-1 compounded On March 3rd, FDA sent multiple sets of warnings to 30 Telehealth companies offering GLP-1s on their websites warning them to refrain from improperly using a brand when they are not the compounder or claiming equivalency to FDA approved drugs